Latest news
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business WireBusiness Wire · Fri, 07 Aug 2026 20:00:00 GMTFaeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference - Business WireBusiness Wire · Fri, 07 Aug 2026 11:30:00 GMTFaeth Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 18:57:37 GMTFTH Initiated Coverage by Jones Trading -- Rating Set to Buy - GuruFocusGuruFocus · Tue, 04 Aug 2026 18:44:53 GMTFaeth Therapeutics (FTH) Advances Cancer Research with Merger an - GuruFocusGuruFocus · Tue, 04 Aug 2026 13:35:36 GMTFaeth Therapeutics Posts $16.0 Million Q2 Net Loss - Quiver QuantitativeQuiver Quantitative · Tue, 04 Aug 2026 11:46:00 GMTFaeth Therapeutics reports $16.0M Q2 net loss, $186.4M cash and marketable securities - TradingViewTradingView · Tue, 04 Aug 2026 11:43:01 GMTFTH: Strong cash position and clinical progress with PIKTOR, topline data expected by year-end 2026 - TradingViewTradingView · Tue, 04 Aug 2026 11:42:16 GMT